RBC Asset Management Inc. announced on Tuesday series of changes within the RBC Funds lineup, including a reduction in management fees and minimum balance requirements. All changes will be effective July 4.

“These product enhancements are designed to provide greater value, accessibility and clarity to the products we offer to investors,” said Brenda Vince, president, RBC Asset Management Inc. “They reflect our commitment to incorporate the best thinking of our portfolio management team into the RBC Funds so that we can help investors achieve their financial goals.”

The management fee on the Advisor Series of the RBC Blue Chip Canadian Equity Fund will be reduced from 2% to 1.75%. The reduction reflects our ongoing commitment to providing investors with excellent value for their money, as we focus on both the costs of investing and performance.

The minimum investment balance requirement for the RBC Premium Money Market Fund will be reduced from $250,000 to $100,000. The Fund has proven to be a solid option for investors with larger balances seeking liquidity and a competitive yield.

The investment strategy of the RBC Life Science and Technology Fund will be amended as part of the RBC Funds 2006 Simplified Prospectus renewal to permit the portfolio manager to invest in technology and life sciences companies without restriction. Currently the Fund maintains at least a 30% weighting in each of the technology and life sciences sectors.

In addition, the names of the following funds will be changed:
– RBC Dividend Fund becomes RBC Canadian Dividend Fund
-RBC Global Health Sciences Sector Fund becomes RBC Global Health Sciences Fund
-RBC U.S. RSP Index Fund becomes RBC U.S. Index Currency Neutral Fund
-RBC International RSP Index Fund becomes RBC International Index Currency Neutral Fund